June 2024
Healthcare Professionals Seek AI-Powered Personalization and Summarization in Medical Education Content
Healthcare Professionals (HCPs), Artificial Intelligence (AI), Medical Education, Personalization, Summarization
GenScript ProBio Launches New Gene Therapy Production Plant in New Jersey
GenScript ProBio, Gene Therapy, Production Plant, New Jersey, CDMO, Biotech
AbbVie’s Duopa Successor in Parkinson’s Rejected Again Due to Third-Party Manufacturer Issues
AbbVie, Duopa, Parkinson’s disease, FDA rejection, third-party manufacturer, ABBV-951, carbidopa, levodopa, subcutaneous pump device
Haleon Sells Nicotine Replacement Therapy Business to Dr. Reddy’s for $630 Million
Haleon, Dr. Reddy’s, nicotine replacement therapy, business sale, $630 million
Sanofi Seeks Private Equity Bids for $20 Billion Consumer Health Division
Sanofi, Consumer Health, Private Equity, Bids, $20 Billion
CRISPR Gene Editing Therapy Can Be Administered Twice, Intellia Study Suggests
CRISPR, gene editing, Intellia Therapeutics, transthyretin amyloidosis, gene therapy, re-dosing
Arrowhead Pharmaceuticals Shifts Focus to Plozasiran, Deprioritizes Zodasiran in Cardiometabolic Drug Development
Arrowhead Pharmaceuticals, cardiometabolic drug, plozasiran, zodasiran, RNAi therapies, cardiovascular disease, triglycerides, LDL cholesterol
Zealand Raises $1 Billion to Advance Amylin Obesity Drug and Seek Partnership
Zealand Pharma, Obesity, Amylin, Weight Loss, $1 Billion Raise, Partnership
Curie.Bio Raises $380M to Support Early-Stage Biotechs
Curie.Bio, biotech accelerator, venture capital, Series A rounds, early-stage biotechs, Alexis Borisy, Zach Weinberg
Formation Bio Secures $372M Megaround to In-License Over 10 Drugs
Formation Bio, Megaround, In-License, Drugs, Biotech, AI-Focused